| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 1.05e-07 | 7 | 150 | 4 | GO:0034988 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 1.66e-05 | 21 | 150 | 4 | GO:0034987 | |
| GeneOntologyMolecularFunction | high-affinity IgG receptor activity | 5.61e-05 | 2 | 150 | 2 | GO:0019771 | |
| GeneOntologyMolecularFunction | leukotriene receptor binding | 5.61e-05 | 2 | 150 | 2 | GO:0031774 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.96e-05 | 188 | 150 | 8 | GO:0005201 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 3.09e-11 | 10 | 153 | 6 | GO:0001798 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 3.09e-11 | 10 | 153 | 6 | GO:0002894 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 6.76e-11 | 11 | 153 | 6 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 6.76e-11 | 11 | 153 | 6 | GO:0002892 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 2.48e-10 | 13 | 153 | 6 | GO:0001788 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 7.15e-10 | 15 | 153 | 6 | GO:0001794 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 7.15e-10 | 15 | 153 | 6 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 7.15e-10 | 15 | 153 | 6 | GO:0002445 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 1.75e-09 | 17 | 153 | 6 | GO:0002866 | |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 3.78e-09 | 19 | 153 | 6 | GO:0002883 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response to antigenic stimulus | 1.37e-08 | 23 | 153 | 6 | GO:0002863 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 2.38e-08 | 25 | 153 | 6 | GO:0002524 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 3.93e-08 | 27 | 153 | 6 | GO:0002864 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte mediated immunity | 7.74e-08 | 30 | 153 | 6 | GO:0002888 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 1.99e-07 | 8 | 153 | 4 | GO:0001812 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 3.56e-07 | 9 | 153 | 4 | GO:0001810 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 5.90e-07 | 10 | 153 | 4 | GO:0016068 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response | 6.35e-07 | 42 | 153 | 6 | GO:0002675 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 6.35e-07 | 42 | 153 | 6 | GO:0002438 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 6.35e-07 | 42 | 153 | 6 | GO:0006910 | |
| GeneOntologyBiologicalProcess | positive regulation of phagocytosis | 7.38e-07 | 99 | 153 | 8 | GO:0050766 | |
| GeneOntologyBiologicalProcess | positive regulation of immunoglobulin mediated immune response | 3.61e-06 | 56 | 153 | 6 | GO:0002891 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell mediated immunity | 3.61e-06 | 56 | 153 | 6 | GO:0002714 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response to antigenic stimulus | 5.99e-06 | 61 | 153 | 6 | GO:0002861 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis | 8.05e-06 | 136 | 153 | 8 | GO:0050764 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response | 1.04e-05 | 67 | 153 | 6 | GO:0002673 | |
| GeneOntologyBiologicalProcess | vacuolar transport | 1.11e-05 | 187 | 153 | 9 | GO:0007034 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | COL16A1 ITGA8 LAMB2 ITGAD ITGAX FREM1 DLC1 ADAMTS9 LPA LRP1 FGG MERTK NPNT | 1.21e-05 | 410 | 153 | 13 | GO:0031589 |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 1.23e-05 | 69 | 153 | 6 | GO:0006911 | |
| GeneOntologyBiologicalProcess | complement activation | 1.34e-05 | 70 | 153 | 6 | GO:0006956 | |
| GeneOntologyBiologicalProcess | lysosomal transport | 1.73e-05 | 151 | 153 | 8 | GO:0007041 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 1.81e-05 | 44 | 153 | 5 | GO:0006958 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 2.50e-05 | 78 | 153 | 6 | GO:0099024 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin mediated immune response | 2.69e-05 | 79 | 153 | 6 | GO:0002889 | |
| GeneOntologyBiologicalProcess | regulation of B cell mediated immunity | 2.69e-05 | 79 | 153 | 6 | GO:0002712 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte mediated immunity | 3.10e-05 | 81 | 153 | 6 | GO:0002886 | |
| GeneOntologyBiologicalProcess | positive regulation of endocytosis | 3.11e-05 | 213 | 153 | 9 | GO:0045807 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 3.47e-05 | 270 | 153 | 10 | GO:0007160 | |
| GeneOntologyBiologicalProcess | membrane invagination | 4.65e-05 | 87 | 153 | 6 | GO:0010324 | |
| GeneOntologyBiologicalProcess | secondary heart field specification | 6.32e-05 | 11 | 153 | 3 | GO:0003139 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 8.11e-05 | 139 | 153 | 7 | GO:0019882 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 9.68e-05 | 62 | 153 | 5 | GO:0002455 | |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 1.19e-04 | 103 | 153 | 6 | GO:0002437 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte mediated immunity | 1.20e-04 | 148 | 153 | 7 | GO:0002444 | |
| GeneOntologyBiologicalProcess | phagocytosis | 2.13e-04 | 274 | 153 | 9 | GO:0006909 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 2.38e-04 | 41 | 153 | 4 | GO:0035909 | |
| GeneOntologyBiologicalProcess | heart field specification | 2.52e-04 | 17 | 153 | 3 | GO:0003128 | |
| GeneOntologyBiologicalProcess | positive regulation of alkaline phosphatase activity | 3.25e-04 | 4 | 153 | 2 | GO:0010694 | |
| GeneOntologyBiologicalProcess | C-terminal protein amino acid modification | 3.55e-04 | 19 | 153 | 3 | GO:0018410 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 4.85e-04 | 244 | 153 | 8 | GO:0019724 | |
| GeneOntologyBiologicalProcess | early endosome to late endosome transport | 5.14e-04 | 50 | 153 | 4 | GO:0045022 | |
| GeneOntologyBiologicalProcess | heart development | TMEM94 SYNPO2L ZFPM1 DIPK2A AXIN2 BMP4 DLC1 ADAMTS9 GALNT11 LRP1 FOXH1 DNAH5 PDLIM2 ODAD3 BICC1 | 5.22e-04 | 757 | 153 | 15 | GO:0007507 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL7A1 COL16A1 ITGA8 LAMB2 AXIN2 ADAMTS9 LPA ADAMTS16 LRP1 NPNT | 5.24e-04 | 377 | 153 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL7A1 COL16A1 ITGA8 LAMB2 AXIN2 ADAMTS9 LPA ADAMTS16 LRP1 NPNT | 5.35e-04 | 378 | 153 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | type III hypersensitivity | 5.39e-04 | 5 | 153 | 2 | GO:0001802 | |
| GeneOntologyBiologicalProcess | regulation of type III hypersensitivity | 5.39e-04 | 5 | 153 | 2 | GO:0001803 | |
| GeneOntologyBiologicalProcess | positive regulation of type III hypersensitivity | 5.39e-04 | 5 | 153 | 2 | GO:0001805 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 5.39e-04 | 5 | 153 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL7A1 COL16A1 ITGA8 LAMB2 AXIN2 ADAMTS9 LPA ADAMTS16 LRP1 NPNT | 5.46e-04 | 379 | 153 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 5.86e-04 | 91 | 153 | 5 | GO:0033627 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response | 6.05e-04 | 193 | 153 | 7 | GO:0050729 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 6.16e-04 | 92 | 153 | 5 | GO:0048844 | |
| GeneOntologyBiologicalProcess | acute inflammatory response | 7.00e-04 | 143 | 153 | 6 | GO:0002526 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport between endosomal compartments | 7.92e-04 | 56 | 153 | 4 | GO:0098927 | |
| GeneOntologyBiologicalProcess | regulation of alkaline phosphatase activity | 8.04e-04 | 6 | 153 | 2 | GO:0010692 | |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 8.04e-04 | 6 | 153 | 2 | GO:0048682 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 8.98e-04 | 150 | 153 | 6 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 8.98e-04 | 150 | 153 | 6 | GO:0002708 | |
| GeneOntologyBiologicalProcess | platelet formation | 9.18e-04 | 26 | 153 | 3 | GO:0030220 | |
| GeneOntologyBiologicalProcess | circulatory system development | GPLD1 NPR1 MYLK TMEM94 SYNPO2L ZFPM1 CHI3L1 ITGAX DIPK2A AXIN2 CFD BMP4 DLC1 ADAMTS9 GALNT11 LPA LRP1 FOXH1 DNAH5 PDLIM2 ODAD3 BICC1 | 9.83e-04 | 1442 | 153 | 22 | GO:0072359 |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | IRGM LILRA1 VPS54 ZFPM1 BMP4 FASN CSF1R IGHG1 IGHG2 IGHG3 IGHG4 MERTK IL27 | 9.88e-04 | 640 | 153 | 13 | GO:1903131 |
| GeneOntologyBiologicalProcess | platelet morphogenesis | 1.14e-03 | 28 | 153 | 3 | GO:0036344 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | PAPPA2 ATG9B MYLK CYP27B1 SYNPO2L ITGA8 CDH23 LAMB2 ZFPM1 ITGAX FREM1 AXIN2 BMP4 DLC1 CSF1R ADAMTS9 RECQL4 ADAMTS16 FOXH1 NPNT | 1.15e-03 | 1269 | 153 | 20 | GO:0009887 |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 1.16e-03 | 62 | 153 | 4 | GO:0035306 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 3.12e-06 | 14 | 160 | 4 | GO:0071735 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 7.28e-06 | 17 | 160 | 4 | GO:0042571 | |
| GeneOntologyCellularComponent | external side of plasma membrane | SELE LILRA1 ITGA8 ITGAD ITGAX FCGR1A FCGR1BP IGHG1 IGHG2 IGHG3 IGHG4 CD163L1 LPA LRP1 FGG | 1.13e-05 | 519 | 160 | 15 | GO:0009897 |
| GeneOntologyCellularComponent | cell surface | SELE LILRA1 FOLH1 ITGA8 RTN4RL1 ITGAD ITGAX SLC4A1 ARSB CSF1R FCGR1A FCGR1BP ADAMTS9 IGHG1 IGHG2 IGHG3 IGHG4 CD163L1 LPA LRP1 FGG IL27 | 4.05e-05 | 1111 | 160 | 22 | GO:0009986 |
| GeneOntologyCellularComponent | side of membrane | SELE LILRA1 ITGA8 RTN4RL1 ITGAD ITGAX SLC4A1 RASAL3 FCGR1A FCGR1BP IGHG1 IGHG2 IGHG3 IGHG4 CD163L1 LPA LRP1 FGG | 1.34e-04 | 875 | 160 | 18 | GO:0098552 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 4.80e-04 | 129 | 160 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | extracellular matrix | GPLD1 COL7A1 COL16A1 LAMB2 RTN4RL1 CHI3L1 FREM1 HMCN2 ADAMTS9 LPA ADAMTS16 FGG MUC2 NPNT | 5.34e-04 | 656 | 160 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | GPLD1 COL7A1 COL16A1 LAMB2 RTN4RL1 CHI3L1 FREM1 HMCN2 ADAMTS9 LPA ADAMTS16 FGG MUC2 NPNT | 5.50e-04 | 658 | 160 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | cell cortex | 5.93e-04 | 371 | 160 | 10 | GO:0005938 | |
| GeneOntologyCellularComponent | blood microparticle | 8.56e-04 | 144 | 160 | 6 | GO:0072562 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.07e-03 | 332 | 160 | 9 | GO:0005788 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.08e-03 | 59 | 160 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 1.78e-03 | 166 | 160 | 6 | GO:0019814 | |
| GeneOntologyCellularComponent | integrin complex | 1.85e-03 | 32 | 160 | 3 | GO:0008305 | |
| MousePheno | absent memory B cells | 4.50e-09 | 4 | 116 | 4 | MP:0008094 | |
| MousePheno | decreased memory B cell number | 5.49e-07 | 9 | 116 | 4 | MP:0008729 | |
| MousePheno | decreased IgG2c level | 1.42e-06 | 11 | 116 | 4 | MP:0008897 | |
| MousePheno | abnormal memory B cell number | 1.42e-06 | 11 | 116 | 4 | MP:0008093 | |
| MousePheno | abnormal memory B cell morphology | 4.23e-06 | 14 | 116 | 4 | MP:0002440 | |
| MousePheno | abnormal plasma cell differentiation | 5.73e-06 | 15 | 116 | 4 | MP:0008099 | |
| MousePheno | enhanced humoral immune response | 9.86e-06 | 17 | 116 | 4 | MP:0020155 | |
| MousePheno | situs inversus with levocardia | 1.90e-05 | 7 | 116 | 3 | MP:0011253 | |
| MousePheno | abnormal IgG2c level | 2.42e-05 | 21 | 116 | 4 | MP:0020178 | |
| MousePheno | abnormal type I hypersensitivity reaction | 6.88e-05 | 84 | 116 | 6 | MP:0002531 | |
| MousePheno | abnormal hypersensitivity reaction | 9.95e-05 | 174 | 116 | 8 | MP:0002148 | |
| MousePheno | increased germinal center B cell number | 1.19e-04 | 31 | 116 | 4 | MP:0008177 | |
| MousePheno | absent cornea epithelium | 2.04e-04 | 3 | 116 | 2 | MP:0020856 | |
| Domain | NPIP | 5.69e-14 | 14 | 156 | 8 | IPR009443 | |
| Domain | Int_alpha | 1.65e-05 | 19 | 156 | 4 | SM00191 | |
| Domain | Int_alpha_beta-p | 1.65e-05 | 19 | 156 | 4 | IPR013519 | |
| Domain | FG_GAP | 3.05e-05 | 22 | 156 | 4 | PS51470 | |
| Domain | FG-GAP | 4.37e-05 | 24 | 156 | 4 | PF01839 | |
| Domain | FG-GAP | 4.37e-05 | 24 | 156 | 4 | IPR013517 | |
| Domain | GCR_153/162 | 6.93e-05 | 2 | 156 | 2 | IPR022347 | |
| Domain | Integrin_alpha | 8.98e-05 | 11 | 156 | 3 | PF00357 | |
| Domain | Integrin_alpha_C_CS | 2.96e-04 | 16 | 156 | 3 | IPR018184 | |
| Domain | Integrin_alpha-2 | 4.25e-04 | 18 | 156 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 4.25e-04 | 18 | 156 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 4.25e-04 | 18 | 156 | 3 | PF08441 | |
| Domain | Integrin_alpha | 4.25e-04 | 18 | 156 | 3 | IPR000413 | |
| Domain | WSC | 6.82e-04 | 5 | 156 | 2 | SM00321 | |
| Domain | WSC | 6.82e-04 | 5 | 156 | 2 | PS51212 | |
| Domain | WSC_carb-bd | 6.82e-04 | 5 | 156 | 2 | IPR002889 | |
| Domain | WSC | 6.82e-04 | 5 | 156 | 2 | PF01822 | |
| Domain | Ig-like_fold | PAPPA2 COL7A1 LILRA1 STBD1 MYLK CSF1R HMCN2 FCGR1A FCGR1BP IGHG1 IGHG2 IGHG3 IGHG4 IGSF9B MERTK | 8.59e-04 | 706 | 156 | 15 | IPR013783 |
| Domain | IG_LIKE | LILRA1 MYLK CSF1R HMCN2 FCGR1A FCGR1BP IGHG1 IGHG2 IGHG3 IGHG4 IGSF9B MERTK | 8.76e-04 | 491 | 156 | 12 | PS50835 |
| Domain | FAD-bd | 1.02e-03 | 6 | 156 | 2 | IPR002938 | |
| Domain | FAD_binding_3 | 1.02e-03 | 6 | 156 | 2 | PF01494 | |
| Domain | C1-set | 1.07e-03 | 54 | 156 | 4 | PF07654 | |
| Domain | Ig-like_dom | LILRA1 MYLK CSF1R HMCN2 FCGR1A FCGR1BP IGHG1 IGHG2 IGHG3 IGHG4 IGSF9B MERTK | 1.08e-03 | 503 | 156 | 12 | IPR007110 |
| Domain | Integrin_dom | 1.15e-03 | 25 | 156 | 3 | IPR032695 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.28e-06 | 48 | 114 | 6 | MM17214 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 5.72e-06 | 56 | 114 | 6 | MM14815 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.38e-05 | 76 | 114 | 6 | MM14867 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 3.79e-05 | 114 | 114 | 7 | MM14814 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.37e-05 | 85 | 114 | 6 | M16441 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 7.30e-05 | 54 | 114 | 5 | MM14655 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL7A1 COL16A1 ITGA8 LAMB2 ITGAD ITGAX BMP4 ADAMTS9 ADAMTS16 FGG | 1.58e-04 | 300 | 114 | 10 | M610 |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.91e-04 | 66 | 114 | 5 | M18 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.36e-04 | 69 | 114 | 5 | M27108 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 2.68e-04 | 39 | 114 | 4 | MM17212 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 4.70e-04 | 80 | 114 | 5 | M6121 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 5.26e-04 | 82 | 114 | 5 | M27110 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 5.88e-04 | 84 | 114 | 5 | MM14653 | |
| Pathway | REACTOME_FORMATION_OF_THE_URETERIC_BUD | 6.16e-04 | 21 | 114 | 3 | M48244 | |
| Pubmed | FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. | 3.11e-13 | 8 | 167 | 6 | 11911823 | |
| Pubmed | 3.11e-13 | 8 | 167 | 6 | 21037092 | ||
| Pubmed | FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. | 9.29e-13 | 9 | 167 | 6 | 20974962 | |
| Pubmed | Cloning and complete nucleotide sequence of mouse immunoglobulin gamma 1 chain gene. | 9.29e-13 | 9 | 167 | 6 | 115593 | |
| Pubmed | 5.07e-12 | 11 | 167 | 6 | 11911824 | ||
| Pubmed | 2.98e-10 | 9 | 167 | 5 | 29118245 | ||
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 5.13e-10 | 4 | 167 | 4 | 113776 | |
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 5.13e-10 | 4 | 167 | 4 | 11812141 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6794027 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 5.13e-10 | 4 | 167 | 4 | 2510996 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 5.13e-10 | 4 | 167 | 4 | 1754385 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 5.13e-10 | 4 | 167 | 4 | 19050247 | |
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 5.13e-10 | 4 | 167 | 4 | 30287618 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 7892607 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 4565406 | ||
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 5.13e-10 | 4 | 167 | 4 | 25363774 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 20621099 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 5.13e-10 | 4 | 167 | 4 | 12414967 | |
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 5.13e-10 | 4 | 167 | 4 | 8438159 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 4098598 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6253932 | ||
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 5.13e-10 | 4 | 167 | 4 | 6769752 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 5.13e-10 | 4 | 167 | 4 | 6803173 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6264445 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 5.13e-10 | 4 | 167 | 4 | 25867470 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 1542303 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 9725203 | ||
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 5.13e-10 | 4 | 167 | 4 | 9126488 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 8452816 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 4831970 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 7439686 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6278424 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 35133976 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 8099342 | ||
| Pubmed | Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation. | 5.13e-10 | 4 | 167 | 4 | 32006024 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 12209645 | ||
| Pubmed | Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. | 5.13e-10 | 4 | 167 | 4 | 117549 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 116231 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 25451975 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 5.13e-10 | 4 | 167 | 4 | 6283537 | |
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 5.13e-10 | 4 | 167 | 4 | 6801765 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6306571 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 1672339 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 5.13e-10 | 4 | 167 | 4 | 1713710 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6777755 | ||
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 5.13e-10 | 4 | 167 | 4 | 9103199 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6297797 | ||
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 5.13e-10 | 4 | 167 | 4 | 98524 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 38268239 | ||
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 5.13e-10 | 4 | 167 | 4 | 6799207 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6787604 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6170065 | ||
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 5.13e-10 | 4 | 167 | 4 | 19703988 | |
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 5.13e-10 | 4 | 167 | 4 | 6767246 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 12051834 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 8683112 | ||
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 5.13e-10 | 4 | 167 | 4 | 807855 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 4166666 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 26201558 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6249338 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6804950 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 5.13e-10 | 4 | 167 | 4 | 19592272 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 10720538 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 24752300 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 15699144 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 2513486 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 36763580 | ||
| Pubmed | Independent immunoglobulin class-switch events occurring in a single myeloma cell line. | 5.13e-10 | 4 | 167 | 4 | 3921826 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 6262729 | ||
| Pubmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. | 5.13e-10 | 4 | 167 | 4 | 26683050 | |
| Pubmed | Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. | 5.13e-10 | 4 | 167 | 4 | 6766534 | |
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 2.55e-09 | 5 | 167 | 4 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 2.55e-09 | 5 | 167 | 4 | 6770027 | |
| Pubmed | Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. | 2.55e-09 | 5 | 167 | 4 | 7704573 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 2.55e-09 | 5 | 167 | 4 | 20031218 | |
| Pubmed | A novel allele for inducible Cre expression in germinal center BÂ cells. | 2.55e-09 | 5 | 167 | 4 | 30359469 | |
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 9834201 | ||
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 103631 | ||
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 33163250 | ||
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 37310381 | ||
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 36853944 | ||
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 23423996 | ||
| Pubmed | The disulphide bridges of a mouse immunoglobulin G1 protein. | 2.55e-09 | 5 | 167 | 4 | 5073237 | |
| Pubmed | Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. | 2.55e-09 | 5 | 167 | 4 | 35044826 | |
| Pubmed | Sequential class switching is required for the generation of high affinity IgE antibodies. | 2.55e-09 | 5 | 167 | 4 | 22249450 | |
| Pubmed | The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program. | 2.55e-09 | 5 | 167 | 4 | 26620759 | |
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 32640012 | ||
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 32229726 | ||
| Pubmed | Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation. | 2.55e-09 | 5 | 167 | 4 | 34539636 | |
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 3031474 | ||
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 33025844 | ||
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 36779803 | ||
| Pubmed | Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. | 2.55e-09 | 5 | 167 | 4 | 6798155 | |
| Pubmed | IgG1 cytoplasmic tail is essential for cell surface expression in Igβ down-regulated cells. | 2.55e-09 | 5 | 167 | 4 | 24548411 | |
| Pubmed | Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. | 2.55e-09 | 5 | 167 | 4 | 6781756 | |
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 27167731 | ||
| Pubmed | Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). | 2.55e-09 | 5 | 167 | 4 | 9743367 | |
| Pubmed | Molecular and cellular basis of the retrovirus resistance in I/LnJ mice. | 2.55e-09 | 5 | 167 | 4 | 16301663 | |
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 9707605 | ||
| Cytoband | 16p11.2 | 6.71e-06 | 191 | 166 | 7 | 16p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 7.40e-05 | 278 | 166 | 7 | chr16p11 | |
| Cytoband | 16p13.11 | 7.80e-05 | 23 | 166 | 3 | 16p13.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 1.73e-04 | 426 | 166 | 8 | chr16p13 | |
| Cytoband | 5p15 | 2.70e-04 | 7 | 166 | 2 | 5p15 | |
| Cytoband | 16p12.2 | 3.30e-04 | 37 | 166 | 3 | 16p12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 4.23e-04 | 172 | 166 | 5 | chr16p12 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 1.46e-04 | 18 | 105 | 3 | 1160 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.35e-04 | 57 | 105 | 4 | 1179 | |
| GeneFamily | Immunoglobulin like domain containing | 9.18e-04 | 193 | 105 | 6 | 594 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.10e-03 | 394 | 105 | 8 | 471 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS | 7.75e-06 | 21 | 162 | 4 | M39281 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_MYELOID_CELLS | 2.07e-05 | 185 | 162 | 8 | M40148 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 2.15e-05 | 186 | 162 | 8 | MM498 | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | LILRA1 LAMB2 CHI3L1 ITGAX CFD MTMR11 CSF1R FCGR1A FCGR1BP LRP1 MERTK | 2.33e-10 | 199 | 165 | 11 | 6795ff31f92580195c9db776951f99d647484d24 |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | LILRA1 LAMB2 CHI3L1 ITGAX CFD MTMR11 CSF1R FCGR1A FCGR1BP LRP1 MERTK | 2.33e-10 | 199 | 165 | 11 | 241f790cd5d8a9b2451333deecc826a673bae70a |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | LILRA1 LAMB2 CHI3L1 ITGAX CFD MTMR11 CSF1R FCGR1A FCGR1BP LRP1 MERTK | 2.33e-10 | 199 | 165 | 11 | dcee372774c169a3048bdaed3734b3215bf8ffad |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | LILRA1 LAMB2 CHI3L1 ITGAX CFD MTMR11 CSF1R FCGR1A FCGR1BP LRP1 MERTK | 2.33e-10 | 199 | 165 | 11 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | COL16A1 MYLK ITGA8 CHI3L1 FREM1 CFD BMP4 ABCA6 LPA LRP1 BICC1 | 2.46e-10 | 200 | 165 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-09 | 192 | 165 | 10 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | LILRA1 LAMB2 GPR162 ITGAX CFD CSF1R FCGR1A FCGR1BP ABCA6 LRP1 | 3.75e-09 | 198 | 165 | 10 | e684c3934c163aef4d284b69435832d2c9614f2a |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | LILRA1 LAMB2 GPR162 ITGAX CFD CSF1R FCGR1A FCGR1BP ABCA6 LRP1 | 3.75e-09 | 198 | 165 | 10 | a92c0cacb775aca6bbb302bd9e22c081a112a44d |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.93e-09 | 199 | 165 | 10 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.93e-09 | 199 | 165 | 10 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.13e-09 | 200 | 165 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.13e-09 | 200 | 165 | 10 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.13e-09 | 200 | 165 | 10 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.13e-09 | 200 | 165 | 10 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.13e-09 | 200 | 165 | 10 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.13e-09 | 200 | 165 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 8.56e-09 | 159 | 165 | 9 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.45e-08 | 132 | 165 | 8 | 4e37400ae7375e6986f060234c373194603346f8 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.83e-08 | 189 | 165 | 9 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.01e-08 | 195 | 165 | 9 | 3a30479857fc2805df92655c9599389559b1995d | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 5.47e-08 | 197 | 165 | 9 | 67f19dd30adb03300f04219d0295bc1c1788f626 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 5.97e-08 | 199 | 165 | 9 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.97e-08 | 199 | 165 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 5.97e-08 | 199 | 165 | 9 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 6.23e-08 | 200 | 165 | 9 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 6.23e-08 | 200 | 165 | 9 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.23e-08 | 200 | 165 | 9 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.23e-08 | 200 | 165 | 9 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 6.23e-08 | 200 | 165 | 9 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-07 | 163 | 165 | 8 | 66ecd544d7b52e61880b125bf39d1f406af6900a | |
| ToppCell | (5)_Plasma-(5)_Plasma_IgG|(5)_Plasma / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.40e-07 | 70 | 165 | 6 | bfe020c111a27337ed4dc6ee59b74bc36b03eb49 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.25e-07 | 188 | 165 | 8 | 8fc15c8b78fdd1a578e34325011bc5a87a8aab31 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-07 | 190 | 165 | 8 | 7f6dafd5418764d67f6d5ec2153233b791910e81 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-07 | 190 | 165 | 8 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-07 | 190 | 165 | 8 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.92e-07 | 191 | 165 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.15e-07 | 192 | 165 | 8 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.15e-07 | 192 | 165 | 8 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.15e-07 | 192 | 165 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.15e-07 | 192 | 165 | 8 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-07 | 193 | 165 | 8 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.40e-07 | 193 | 165 | 8 | 52f5b0fbb8ca706206c65e7edbb1ddbd380aebae | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-07 | 194 | 165 | 8 | d47e3c7b22444aef0c7a37bc8cd8853b590a56dd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.66e-07 | 194 | 165 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.66e-07 | 194 | 165 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.92e-07 | 195 | 165 | 8 | a4d36654b968acb1aea252ac203683939461f1d1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.92e-07 | 195 | 165 | 8 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.92e-07 | 195 | 165 | 8 | cd811abd949ef201aef1c8515da5575ab1b1cfea | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.19e-07 | 196 | 165 | 8 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.47e-07 | 197 | 165 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 7.47e-07 | 197 | 165 | 8 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | (4)_Monocyte|World / shred on Cell_type and subtype | 7.76e-07 | 198 | 165 | 8 | 56f9ebf902fe81c590696ba4c88028deaf346841 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.06e-07 | 199 | 165 | 8 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 8.06e-07 | 199 | 165 | 8 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 8.06e-07 | 199 | 165 | 8 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.06e-07 | 199 | 165 | 8 | 2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.06e-07 | 199 | 165 | 8 | cefc3b50f65e95da850e4720c7b44bf584073491 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.06e-07 | 199 | 165 | 8 | 9e87b64e16d595701c3beb07aa835afe3330bd10 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.06e-07 | 199 | 165 | 8 | aaa460c389cd6d38a13ba1a446f91a94f9573ad8 | |
| ToppCell | Caecum-(4)_Monocyte-(40)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 8.37e-07 | 200 | 165 | 8 | b078058efc51f0ff4d92123b712933b32824c655 | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 8.37e-07 | 200 | 165 | 8 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | Caecum-(4)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 8.37e-07 | 200 | 165 | 8 | 6bfd6ab395e09087aeedc9a7c9ada1b4b8a26194 | |
| ToppCell | mLN-(6)_Macrophage-(61)_LYVE1_Macrophage|mLN / shred on region, Cell_type, and subtype | 8.37e-07 | 200 | 165 | 8 | a20f5ec61d492d8a2adf695ec304b5d57296aa8f | |
| ToppCell | Caecum-Monocyte|Caecum / Region, Cell class and subclass | 8.37e-07 | 200 | 165 | 8 | 9e8d38d024a315512521b349e8ac7caa56219daf | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|mLN / Region, Cell class and subclass | 8.37e-07 | 200 | 165 | 8 | 89cf739a3c2f5d30e547404f2f2ec6500cd1d65d | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 8.37e-07 | 200 | 165 | 8 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.37e-07 | 200 | 165 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Caecum-Monocyte-Monocyte|Caecum / Region, Cell class and subclass | 8.37e-07 | 200 | 165 | 8 | d33619b6c721eae3ebe50fba6b9d31fa99f2248f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.37e-07 | 200 | 165 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | (60)_Macrophage|World / shred on Cell_type and subtype | 9.72e-07 | 204 | 165 | 8 | 06d0cb306f1ad0014d81f8228868938e48c2bcf3 | |
| ToppCell | (40)_Monocyte|World / shred on Cell_type and subtype | 1.05e-06 | 206 | 165 | 8 | d78a70f951265ef6df8f64404107be4f53e75d28 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_dendritic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.49e-06 | 150 | 165 | 7 | f4aed24b79e1be38abc7a1120256821601893d6d | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.63e-06 | 152 | 165 | 7 | a2ba2d95ac9010e1a62db34dcad10d004f8a90cc | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 153 | 165 | 7 | a8f83ec640fae51d4fba34b92e3d6cca4999e930 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.70e-06 | 153 | 165 | 7 | a156710217ef07c07a80ca6504fa0784d86380fa | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 157 | 165 | 7 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 157 | 165 | 7 | 0966e347f8d32b13f8a3b3afba3f64637c69cdf9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 157 | 165 | 7 | 6ebfedd91d62c6d4aa8f046657a899a279f82ba2 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 157 | 165 | 7 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 157 | 165 | 7 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 157 | 165 | 7 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 158 | 165 | 7 | 0c9bb7f8d080a052ca71701544a076c6c2ea67cd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 158 | 165 | 7 | cebb58878b6945074bc1c7d5848d842da5dcbae1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 158 | 165 | 7 | 2cfa6dd36c8ae534cf1dd49366d4b4433388c1e0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 158 | 165 | 7 | 6b51e5ee08e23924f5edbaf0a845a9232fb7ff7a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 158 | 165 | 7 | 8dd83a2a4c2ec9cdc3a03df8b51ee22bee1c2888 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-06 | 160 | 165 | 7 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.29e-06 | 160 | 165 | 7 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-06 | 165 | 165 | 7 | 9e2fa634f4749e35aa5dca43476477b5d362afd7 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 3.16e-06 | 168 | 165 | 7 | e8bd090de5c9fe286b08a8b314ce12cf988184f0 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 3.29e-06 | 169 | 165 | 7 | a65853ff9f6489cc1617cbba0d03b392d23c1528 | |
| ToppCell | URO-Lymphocyte-B-Plasmablast|URO / Disease, Lineage and Cell Type | 3.69e-06 | 172 | 165 | 7 | 48888ef50ac784b38aca81da68f8a94ce09c670d | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-Plasmablast|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.98e-06 | 174 | 165 | 7 | e8d2aa9505817aac3fe068080774d19458f07b01 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-06 | 177 | 165 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.46e-06 | 177 | 165 | 7 | 95760841b3f085d38c4926b258a33563d93a2016 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-06 | 177 | 165 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.80e-06 | 179 | 165 | 7 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-06 | 180 | 165 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.98e-06 | 180 | 165 | 7 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.98e-06 | 180 | 165 | 7 | d33bb00f2b7d07dda9015cb8eafd742c2b2e9ace | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.40e-05 | 50 | 85 | 5 | GAVISH_3CA_METAPROGRAM_B_CELLS_PLASMA | |
| Disease | neural cell adhesion molecule 1 measurement | 2.57e-05 | 2 | 150 | 2 | EFO_0801826 | |
| Disease | insulin growth factor-like family member 4 measurement | 2.57e-05 | 2 | 150 | 2 | EFO_0801701 | |
| Disease | immunoglobulin G measurement | 2.57e-05 | 2 | 150 | 2 | EFO_0020465 | |
| Disease | ameloblastin measurement | 7.68e-05 | 3 | 150 | 2 | EFO_0801377 | |
| Disease | paired immunoglobulin-like type 2 receptor alpha measurement | 7.68e-05 | 3 | 150 | 2 | EFO_0801866 | |
| Disease | secretoglobin family 1C member 1 measurement | 7.68e-05 | 3 | 150 | 2 | EFO_0802041 | |
| Disease | protein YIPF6 measurement | 7.68e-05 | 3 | 150 | 2 | EFO_0802969 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.23e-04 | 50 | 150 | 4 | C1449563 | |
| Disease | hearing impairment | 1.47e-04 | 98 | 150 | 5 | C1384666 | |
| Disease | di-N-acetylchitobiase measurement | 1.53e-04 | 4 | 150 | 2 | EFO_0801524 | |
| Disease | trem-like transcript 4 protein measurement | 1.53e-04 | 4 | 150 | 2 | EFO_0802160 | |
| Disease | sodium/potassium-transporting ATPase subunit alpha-1 measurement | 1.53e-04 | 4 | 150 | 2 | EFO_0802077 | |
| Disease | RING finger protein 165 measurement | 1.53e-04 | 4 | 150 | 2 | EFO_0802027 | |
| Disease | E3 ubiquitin-protein ligase RNF149 measurement | 1.53e-04 | 4 | 150 | 2 | EFO_0802511 | |
| Disease | rap guanine nucleotide exchange factor 5 measurement | 1.53e-04 | 4 | 150 | 2 | EFO_0802989 | |
| Disease | prolyl 4-hydroxylase subunit alpha-2 measurement | 1.53e-04 | 4 | 150 | 2 | EFO_0802918 | |
| Disease | serum albumin measurement | FAM234B COL7A1 SHROOM3 ZFPM1 FRY ABCA6 IGHG1 IGHG2 IGHG4 LPA UBASH3B | 2.33e-04 | 592 | 150 | 11 | EFO_0004535 |
| Disease | potassium voltage-gated channel subfamily E member 2 measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0801901 | |
| Disease | zinc transporter 3 measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0803287 | |
| Disease | Myositis, Proliferative | 2.54e-04 | 5 | 150 | 2 | C0544796 | |
| Disease | Infectious Myositis | 2.54e-04 | 5 | 150 | 2 | C0158353 | |
| Disease | protein shisa-3 homolog measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0801964 | |
| Disease | toll-like receptor 1 measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0803159 | |
| Disease | tachykinin-4 measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0803137 | |
| Disease | serine/threonine-protein kinase Chk1 measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0021965 | |
| Disease | Congenital absence of kidneys syndrome | 2.54e-04 | 5 | 150 | 2 | C1609433 | |
| Disease | activating signal cointegrator 1 complex subunit 1 measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0801340 | |
| Disease | membrane-associated progesterone receptor component 2 measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0801796 | |
| Disease | Myositis | 2.54e-04 | 5 | 150 | 2 | C0027121 | |
| Disease | Myositis, Focal | 2.54e-04 | 5 | 150 | 2 | C0751357 | |
| Disease | Idiopathic Inflammatory Myopathies | 2.54e-04 | 5 | 150 | 2 | C0751356 | |
| Disease | pre-mRNA-processing factor 6 measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0802894 | |
| Disease | E3 ubiquitin-protein ligase RNF128 measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0801555 | |
| Disease | thymidine kinase, cytosolic measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0020773 | |
| Disease | rab9 effector protein with kelch motifs measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0801984 | |
| Disease | o-acetyl-ADP-ribose deacetylase MACROD1 measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0802827 | |
| Disease | complement component 1 q subcomponent-binding protein, mitochondrial measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0020280 | |
| Disease | thioredoxin-interacting protein measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0803149 | |
| Disease | carcinoembryonic antigen-related cell adhesion molecule 1 measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0801456 | |
| Disease | beta-sarcoglycan measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0801422 | |
| Disease | multiple coagulation factor deficiency protein 2 measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0801810 | |
| Disease | complement C1q subcomponent measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0008089 | |
| Disease | Prolactinoma | 3.80e-04 | 6 | 150 | 2 | C0033375 | |
| Disease | ribosome biogenesis protein TSR3 homolog measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0803025 | |
| Disease | CCAAT/enhancer-binding protein beta measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0021905 | |
| Disease | leucine-rich repeat and fibronectin type III domain-containing protein 1 measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0802689 | |
| Disease | leucine-rich repeat-containing protein 74A measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0801763 | |
| Disease | secreted frizzled-related protein 2 measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0802039 | |
| Disease | DNA-binding protein SATB2 measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0802484 | |
| Disease | orofacial cleft (is_implicated_in) | 5.30e-04 | 7 | 150 | 2 | DOID:0050567 (is_implicated_in) | |
| Disease | myotubularin-related protein 1 measurement | 5.30e-04 | 7 | 150 | 2 | EFO_0802773 | |
| Disease | inducible T-cell costimulator measurement | 5.30e-04 | 7 | 150 | 2 | EFO_0021967 | |
| Disease | kv channel-interacting protein 1 measurement | 5.30e-04 | 7 | 150 | 2 | EFO_0801751 | |
| Disease | alpha-1-antichymotrypsin complex measurement | 5.30e-04 | 7 | 150 | 2 | EFO_0008018 | |
| Disease | RNA polymerase II elongation factor ELL measurement | 5.30e-04 | 7 | 150 | 2 | EFO_0802028 | |
| Disease | nephrosis (implicated_via_orthology) | 5.30e-04 | 7 | 150 | 2 | DOID:2527 (implicated_via_orthology) | |
| Disease | sphingomyelin measurement | 5.72e-04 | 278 | 150 | 7 | EFO_0010118 | |
| Disease | ovarian neoplasm | 6.26e-04 | 134 | 150 | 5 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 6.92e-04 | 137 | 150 | 5 | C1140680 | |
| Disease | cytochrome c oxidase assembly factor 3 homolog, mitochondrial measurement | 7.04e-04 | 8 | 150 | 2 | EFO_0801513 | |
| Disease | Unilateral agenesis of kidney | 7.04e-04 | 8 | 150 | 2 | C0266294 | |
| Disease | growth factor receptor-bound protein 7 measurement | 7.04e-04 | 8 | 150 | 2 | EFO_0801659 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 7.04e-04 | 8 | 150 | 2 | EFO_0008309 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 8.81e-04 | 37 | 150 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | colorectal carcinoma (is_marker_for) | 8.81e-04 | 37 | 150 | 3 | DOID:0080199 (is_marker_for) | |
| Disease | cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0801514 | |
| Disease | RNA-binding protein 24 measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0802030 | |
| Disease | glutamate carboxypeptidase 2 measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0020408 | |
| Disease | Hypercholesterolemia | 1.03e-03 | 39 | 150 | 3 | C0020443 | |
| Disease | peak expiratory flow | 1.05e-03 | 498 | 150 | 9 | EFO_0009718 | |
| Disease | brain ischemia (is_implicated_in) | 1.12e-03 | 10 | 150 | 2 | DOID:2316 (is_implicated_in) | |
| Disease | transcription factor IIIb 90 kda subunit measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0020778 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0801535 | |
| Disease | OCIA domain-containing protein 1 measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0008252 | |
| Disease | axin-2 measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0801400 | |
| Disease | cytochrome p450 3a4 measurement | 1.37e-03 | 11 | 150 | 2 | EFO_0020303 | |
| Disease | Barrett's esophagus (is_marker_for) | 1.37e-03 | 11 | 150 | 2 | DOID:9206 (is_marker_for) | |
| Disease | guanylate-binding protein 6 measurement | 1.37e-03 | 11 | 150 | 2 | EFO_0801662 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.64e-03 | 12 | 150 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | Thromboembolism | 1.64e-03 | 12 | 150 | 2 | C0040038 | |
| Disease | Cardiomyopathy, Dilated | 1.88e-03 | 48 | 150 | 3 | C0007193 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 1.93e-03 | 13 | 150 | 2 | EFO_0802114 | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 1.93e-03 | 13 | 150 | 2 | EFO_0010617 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.12e-03 | 50 | 150 | 3 | EFO_0022334 | |
| Disease | corneal resistance factor | 2.23e-03 | 451 | 150 | 8 | EFO_0010067 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.24e-03 | 51 | 150 | 3 | cv:CN043650 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.24e-03 | 14 | 150 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | cardiovascular disease | 2.42e-03 | 457 | 150 | 8 | EFO_0000319 | |
| Disease | Situs ambiguus | 2.58e-03 | 15 | 150 | 2 | C0266642 | |
| Disease | S-6-hydroxywarfarin measurement | 2.85e-03 | 368 | 150 | 7 | EFO_0803326 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 3.24e-03 | 58 | 150 | 3 | EFO_0022338 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 4.15e-03 | 19 | 150 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | selenium measurement, response to dietary selenium supplementation | 4.59e-03 | 20 | 150 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | Arthrogryposis | 5.06e-03 | 21 | 150 | 2 | C0003886 | |
| Disease | Benign Neoplasm | 5.07e-03 | 68 | 150 | 3 | C0086692 | |
| Disease | Neoplasms | 5.07e-03 | 68 | 150 | 3 | C0027651 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QHLSWAFPGTAGPGL | 141 | Q8N2C9 | |
| SGWIQGLRSLAQHPS | 121 | Q6PJG6 | |
| PHSAGGASLSVRWVQ | 11 | Q8NDM7 | |
| SNSSARGWVIHPLGL | 641 | P02730 | |
| LLGLWATFGHGANTG | 11 | Q07092 | |
| HIGLWTGLPDGSFFL | 1006 | Q8N139 | |
| SVLGWNHPGFAGSTG | 306 | O95870 | |
| SPWVHITLGDGSTFQ | 186 | Q9Y2Z9 | |
| SSPGERASRHHLWGG | 651 | Q9Y2T1 | |
| GRFTAHWRVPLLTAG | 126 | P16066 | |
| TVSAHFGEGSGPIWL | 1086 | Q9NR16 | |
| LAAIGSTHGHRWVPG | 81 | Q96MC9 | |
| HVRISRSLPQGSGNW | 251 | P12644 | |
| WRDRNGIGPGSHSEF | 816 | Q9H694 | |
| DLWNSPTRTHGTFGR | 3161 | Q9H251 | |
| GAVSGVPTWTGHRGI | 1306 | Q03468 | |
| HLSWKLGRAAQGSSP | 186 | Q8TE57 | |
| PRGGVIQSVSSWKHG | 346 | Q96B23 | |
| RGTDFGGSPWLHVII | 51 | Q92617 | |
| SGGTRGWLPSHEGHL | 116 | Q15415 | |
| HGNKLWSLGPGTFRG | 181 | Q86UN2 | |
| GRFAGWGRALSHQEP | 41 | Q86YV0 | |
| GGGSSFRPLHKPQWF | 516 | O75943 | |
| HPWGRFGAALTVLGD | 516 | P20702 | |
| HRGTDFGGSPWLLII | 31 | Q9UND3 | |
| RGTDFGGSPWLHVII | 51 | F8W0I5 | |
| AGWGIVNHAGRRPDS | 151 | P00746 | |
| HFGPVWLASFGTVRT | 71 | O15528 | |
| FGNAVPGLTFHWSVT | 1201 | Q8TEM1 | |
| LTSFGRIPWPHAGVG | 56 | Q9Y442 | |
| LHLPGSSSTQWFLNG | 46 | Q92637 | |
| HAGPLWVRGSLVLFG | 156 | Q7RTS5 | |
| WPHNFSGLFLLTVGS | 311 | Q86WK9 | |
| WHRNGQPITSGGRFL | 66 | Q15746 | |
| GFPGLGSAQTWLTLV | 21 | Q6IF63 | |
| SGGHRASLWGQLPTS | 266 | O75593 | |
| TFPSSGRWGGHRLGN | 1466 | Q2M2H8 | |
| GGHGWRQTQITLRGA | 516 | Q6UXI9 | |
| TAHSILISWVPGFDG | 296 | Q12866 | |
| FILSTLPSIGWHNNG | 146 | Q16538 | |
| WVAAGHPFLTRLGGT | 411 | A4FU01 | |
| LSNGSTHQLWGGPPF | 376 | Q8NDA2 | |
| VHRETGSGGWPNGLT | 1426 | Q07954 | |
| SHFSNVVLWDLPGTG | 81 | A1A4Y4 | |
| GHRDSWVFGGIDPQS | 376 | Q04609 | |
| VRLGHDNTGKAPGWF | 1036 | Q8IVV2 | |
| TGGSRHPAIWIDTGI | 181 | Q8WXQ8 | |
| AWRGTTGHHSPLFRG | 211 | P36222 | |
| GSRWYHGGSQPIQIR | 16 | Q9BPX6 | |
| AWGGGLLHSVGQTFL | 146 | Q8NH49 | |
| SHAGGRPGNWRTATL | 276 | Q02817 | |
| GKPGTFTWQGLSTAH | 1241 | Q1MSJ5 | |
| WSRHLGSQGGGDLSP | 136 | A2RU67 | |
| SSPVVRGGFNWGLHF | 286 | Q8NCW6 | |
| PLNSGGTFSWGDLHT | 831 | Q5H8C1 | |
| RLSLATGLSWGPFHG | 106 | Q8IX07 | |
| TGLSWGPFHGSVQTR | 111 | Q8IX07 | |
| SHAGSLRPGLSASWG | 556 | Q6NV75 | |
| SVTHGNQGPFWLVLS | 236 | Q86UT5 | |
| RWGPGSSVGSLQALS | 1436 | P48681 | |
| GGSRGSPSQEWVIHA | 631 | Q5T7B8 | |
| ARTCGATGHWSGLLP | 531 | P16581 | |
| TPSWTGSGFVRLQEG | 591 | P55268 | |
| RGTDFGGSPWLHVII | 51 | A8MRT5 | |
| ARHALESSFVGWGLP | 841 | Q8TDZ2 | |
| IPRGHQSSFWGRKGA | 281 | Q96FV0 | |
| TRTEGPSVVQGWGHL | 31 | E5RJM6 | |
| HRGTDFGGSPWLLII | 31 | F8WFD2 | |
| WSPRALFHPTGGTQG | 561 | Q96F07 | |
| RGTDFGGSPWLHVII | 51 | C9JG80 | |
| SGVCIHPRFGGWFAI | 146 | Q9Y4U1 | |
| VLQGVWASHAVPSGF | 436 | P53708 | |
| HSWTPARFSGSLLGG | 76 | P04211 | |
| TPPALQLGSGFQHWA | 221 | Q7RTU3 | |
| GEQGHPWGRFGAALT | 511 | Q13349 | |
| RGTDFGGSPWLHIII | 51 | E5RHQ5 | |
| PGLFGVWAHNGEVRT | 611 | Q9Y5E5 | |
| GHLGTLVFWSTALPQ | 421 | Q9BXP8 | |
| FGHLSPTGTTEFWLG | 241 | P02679 | |
| IRSLSHSSPWQARGG | 1846 | Q9Y2I7 | |
| PSRTHVLGGNQWRTG | 1321 | Q9P2N4 | |
| RAHNSVGSGSWAFIP | 486 | P07333 | |
| NKSFGFTLRGHGPVW | 286 | A4D2P6 | |
| NPSWEVRHGAGTGLR | 296 | O14981 | |
| HATWRGTSGGLLHDP | 371 | Q8NDZ4 | |
| FHALLGGLGTQGRWT | 116 | Q8NEV9 | |
| FPWQAFTSIHGRGGG | 256 | Q9NZP8 | |
| RHSTFIPGTNKWAGL | 1751 | P08519 | |
| HWGQSGRAPTQASIR | 176 | Q96PT4 | |
| PGHSSKFLGHLWGRV | 721 | Q674R7 | |
| GWNDVGFHGSRIRTP | 56 | P15848 | |
| LHLPGSSSTQWFLNG | 46 | P12314 | |
| LHSWPNLVFGLTSGG | 281 | Q8NFN8 | |
| HSLLVAWRSVPGATG | 341 | Q02388 | |
| WNSGALTSGVHTFPA | 41 | P01857 | |
| WNSGALTSGVHTFPA | 41 | P01859 | |
| WNSGALTSGVHTFPA | 41 | P01860 | |
| WNSGALTSGVHTFPA | 41 | P01861 | |
| TASHGLRGNGWGSPE | 1396 | Q5TBA9 | |
| GWAKHIPGFSSLSLG | 256 | O95718 | |
| PGQHLATWTLPGRAS | 1906 | A6NE01 | |
| NPDSLRGTHTGVWVG | 96 | P49327 | |
| GESIQGSHVTRWPGV | 596 | O43304 | |
| TGEWKQPHGGALTSR | 141 | P51172 | |
| VWTAQRPGITHGVGL | 456 | P51172 | |
| HSWTPARFSGSLLGG | 76 | A0A075B6I9 | |
| AAGSTWLQGFGRPSV | 31 | Q5SR56 | |
| GTHSPAQLNWRVGTG | 51 | Q8WYK1 | |
| IFIPALRATSHGWGE | 171 | Q8TE73 | |
| VSWNHLRGPGAVAFA | 226 | Q6ZQY2 | |
| RGTDFGGSPWLHVII | 51 | A6NJU9 | |
| ALGTWLGGTIHSLFQ | 166 | Q8NH81 | |
| HRGTDFGGSPWLLII | 31 | E9PJI5 | |
| HRGTDFGGSPWLLII | 31 | P0DM63 | |
| LGPGNRTHIWLFVRG | 26 | P09001 | |
| EGFPLSRWAPGRHGT | 746 | Q9BVN2 | |
| AAGPGTHLSLFWARI | 146 | Q8TDU9 | |
| TRTGLQAHVWRPGAG | 961 | Q9H987 | |
| HGAVWPQISRLGSES | 1181 | O75691 | |
| SAGRGLGAVWSPTHV | 6 | Q6WKZ4 | |
| HLGTRGSNTSWRPGT | 456 | O94941 | |
| SLDNGHSFPRAGTWL | 131 | Q9UGT4 | |
| GRHRVPLASGTAWLG | 751 | Q24JP5 | |
| AWPTVLQTGTRGFHF | 21 | P31040 | |
| GQFPIPSITWEHTGR | 81 | O75019 | |
| QPRTHGWSRAIFSVG | 171 | O75019 | |
| ASASQRPVLFHWTGG | 381 | Q8N135 | |
| HRGTDFGGSPWLLII | 31 | E9PKD4 | |
| RTCLHAAWVPGSGGR | 721 | O94761 | |
| VFGSLGLQPWIGSSR | 56 | Q9UK53 | |
| QAWTPGRSKGGSFHR | 46 | A5D8V7 | |
| SGGHWDGSLRVTALP | 2476 | Q6ZNJ1 | |
| TSGPQHRKAAWSGGV | 131 | Q8TF72 | |
| FSLSNSGPGRGQHWP | 821 | Q9UPS6 | |
| GIWVRTSNGGHFASP | 46 | Q8NC67 | |
| HRGSWFLTGVLGSQP | 361 | P22891 | |
| VNWRTGSFHGPGHIS | 836 | Q96QB1 | |
| GKGWSQNTEGLPSHR | 936 | Q96KW2 | |
| APWGFRITGGRDFHT | 11 | Q96JY6 | |
| WDLGLGHLPRFFGTA | 406 | Q5JTH9 | |
| GSSLTSFQWRPSGHQ | 3501 | Q9NRC6 | |
| GPLTTSHEAFGGINW | 206 | Q9BWW9 | |
| RFWQGSTDHRGVPGK | 31 | Q8WUX2 | |
| VGRGPGFHAGTSALW | 76 | Q96IU2 | |
| FLPHGWSGVLQGAAT | 246 | Q8TBB6 | |
| GFGGHGTRQALWTPD | 366 | Q96KV7 | |
| FALWLGGTVHSLGQT | 146 | Q8NGC2 | |
| TGGRHHFWFLPNLTA | 256 | Q99442 | |
| VPRHSSWGDVGVGGS | 206 | O95210 | |
| GSKPRSGGNHRSWLN | 41 | A6NGZ8 | |
| LTGIVSWGHGSGRPN | 806 | Q7RTY8 | |
| CIWGHFLRVLGGTSP | 381 | Q12767 | |
| GAHGGPSTFGLDTRW | 1156 | Q9UPX0 | |
| LFTVSVDHRGTWNGP | 131 | P51571 | |
| SGEGSRGPHSGVIQW | 11 | Q6ZV50 | |
| PGWSGALRFGFTAHD | 91 | A8MQ27 | |
| LVGSPTWKNASRLGH | 596 | P80108 | |
| LGNHSGGWVPQFLTR | 1471 | O15015 | |
| GGGPALTLWHLRSST | 236 | Q86W42 | |
| WGEDGTPLGHTRFQG | 36 | Q7Z5U6 | |
| HRGTDFGGSPWLRII | 31 | A6NJ64 | |
| HTGGIIRWLGRPSSQ | 66 | Q6ZVL8 | |
| KTRAPQLGGSFAVWG | 56 | Q99595 | |
| CFGVVHRGLWTLPSG | 126 | Q13470 | |
| PLTHGPTGGFNWRET | 631 | Q8TF42 | |
| LSSFPGAGNTWARHL | 356 | Q658N2 | |
| LASFPGAGNTWARHL | 346 | Q2TBF2 | |
| VGGIWIHSSSFPGVT | 601 | O60294 | |
| PTQRGRHTAGGLQAW | 281 | Q9BT76 | |
| SHPLSWGRILFIGGI | 316 | P48651 | |
| GPWGFSHGAIISTCQ | 311 | Q8NDV7 | |
| SVLPWSHFNTAGGKG | 181 | Q9P1Q0 | |
| AGLPHFSSGIFRCWG | 1086 | P35573 | |
| RPGGSTFTIGKSIWL | 621 | O15399 |